Resolve Therapeutics LLC — Form D
Resolve Therapeutics LLC of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-17. The offering totals $5.8M, of which $5.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2013-01-17
- Form: D
- Accession: 0001520680-13-000001
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $5.8M
- Amount sold: $5.8M
- Investors: 6
- Date of first sale: 2012-11-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-190410
Issuer
- Name: Resolve Therapeutics LLC
- CIK: 0001520680
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 454 North 34th Street, Seattle, WA, 98103
- Phone: 208-727-7010
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Peter Kiener | Executive Officer | St. Louis, MO |
| James Posada | Executive Officer | Seattle, WA |
| Somu Subramaniam | Executive Officer | South San Francisco, CA |
| James Posada | Promoter | Seattle, WA |
Other filings by this issuer (2)
More